XML 15 R5.htm IDEA: XBRL DOCUMENT v3.21.2
STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
Total
Common Stock
Additional Paid In Capital
Accumulated Deficit
Balance at Dec. 31, 2019 $ 95,010,000 $ 182,000 $ 778,953,000 $ (684,125,000)
Balance (in shares) at Dec. 31, 2019   181,803,320    
Stock-based compensation 3,601,000   3,601,000  
Exercise of employee stock options 16,000   16,000  
Exercise of employee stock options (in shares)   8,166    
Issuance of restricted common stock 0 $ 1,000 (1,000)  
Issuance of restricted common stock (in shares)   555,900    
Issuance of common stock in connection with a public offering, net 88,661,000 $ 29,000 88,632,000  
Issuance of common stock in connection with a public offering, net (in shares)   29,110,111    
Issuance of common stock in connection with at the market offering, net 13,015,000 $ 2,000 13,013,000  
Issuance of common stock in connection with at the market offering, net (in shares)   2,814,673    
Net loss (36,889,000)     (36,889,000)
Balance at Jun. 30, 2020 163,414,000 $ 214,000 884,214,000 (721,014,000)
Balance (in shares) at Jun. 30, 2020   214,292,170    
Balance at Mar. 31, 2020 180,337,000 $ 214,000 882,541,000 (702,418,000)
Balance (in shares) at Mar. 31, 2020   214,286,337    
Stock-based compensation 1,661,000   1,661,000  
Exercise of employee stock options 12,000   12,000  
Exercise of employee stock options (in shares)   5,833    
Net loss (18,596,000)     (18,596,000)
Balance at Jun. 30, 2020 163,414,000 $ 214,000 884,214,000 (721,014,000)
Balance (in shares) at Jun. 30, 2020   214,292,170    
Balance at Dec. 31, 2020 123,982,000 $ 215,000 887,868,000 (764,101,000)
Balance (in shares) at Dec. 31, 2020   214,591,906    
Stock-based compensation 7,486,000   7,486,000  
Exercise of employee stock options $ 1,036,000 $ 0 1,036,000  
Exercise of employee stock options (in shares) 363,109 363,109    
Restricted stock awards $ 1,000 $ 1,000 0  
Restricted stock awards (in shares)   726,224    
Cancelled restricted common stock 0 $ 0    
Cancelled restricted common stock (in shares)   122,091    
Net loss (44,224,000)     (44,224,000)
Balance at Jun. 30, 2021 88,281,000 $ 216,000 896,390,000 (808,325,000)
Balance (in shares) at Jun. 30, 2021   215,559,148    
Balance at Mar. 31, 2021 105,641,000 $ 215,000 891,081,000 (785,655,000)
Balance (in shares) at Mar. 31, 2021   215,257,674    
Stock-based compensation 5,290,000   5,290,000  
Exercise of employee stock options 20,000   20,000  
Exercise of employee stock options (in shares)   10,667    
Restricted stock awards 0 $ 1,000 1,000  
Restricted stock awards (in shares)   412,898    
Cancelled restricted common stock (in shares)   122,091    
Net loss (22,670,000)     (22,670,000)
Balance at Jun. 30, 2021 $ 88,281,000 $ 216,000 $ 896,390,000 $ (808,325,000)
Balance (in shares) at Jun. 30, 2021   215,559,148